BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7987251)

  • 1. A model demonstrating different interactions of human coagulation factor XII (Hageman factor) with the surface at physiological and lower pH.
    Samuel E; Samuel M; Villanueva GB
    Biochem Mol Biol Int; 1994 Aug; 33(5):827-34. PubMed ID: 7987251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextran sulphate inhibits phospholipid and sulphatide mediated autoactivation of factor XII.
    Schousboe I; Rasmussen MS; Lintner R
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):503-9. PubMed ID: 7841305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histidine residues are essential for the surface binding and autoactivation of human coagulation factor XII.
    Samuel M; Samuel E; Villanueva GB
    Biochem Biophys Res Commun; 1993 Feb; 191(1):110-7. PubMed ID: 8447816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human factor XII (Hageman factor) autoactivation by dextran sulfate. Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studies.
    Samuel M; Pixley RA; Villanueva MA; Colman RW; Villanueva GB
    J Biol Chem; 1992 Sep; 267(27):19691-7. PubMed ID: 1527088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The autoactivation of factor XII in the presence of long-chain saturated fatty acids--a comparison with the potency of sulphatides and dextran sulphate.
    Mitropoulos KA; Esnouf MP
    Thromb Haemost; 1991 Oct; 66(4):446-52. PubMed ID: 1796394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII.
    Schousboe I; Nystrøm BT; Hansen GH
    FEBS J; 2008 Oct; 275(20):5161-72. PubMed ID: 18793325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoactivation of human blood coagulation factor XII on dextran derivatives of different molecular weight.
    Tazi S; Tans G; Hemker HC; Nigretto JM
    Thromb Res; 1992 Sep; 67(6):665-76. PubMed ID: 1279836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor).
    Schousboe I
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):671-8. PubMed ID: 7507361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XII fragment and kallikrein generation in plasma during incubation with biomaterials.
    van der Kamp KW; van Oeveren W
    J Biomed Mater Res; 1994 Mar; 28(3):349-52. PubMed ID: 7521336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfatide-dependent autoactivation of human blood coagulation Factor XII (Hageman Factor).
    Tans G; Rosing J; Griffin JH
    J Biol Chem; 1983 Jul; 258(13):8215-22. PubMed ID: 6553053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface-independent acceleration of factor XII activation by zinc ions. I. Kinetic characterization of the metal ion rate enhancement.
    Bernardo MM; Day DE; Olson ST; Shore JD
    J Biol Chem; 1993 Jun; 268(17):12468-76. PubMed ID: 8509386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The low pH stability of human coagulation factor XII (Hageman factor) is due to reversible conformational transitions.
    Samuel M; Samuel E; Villanueva GB
    Thromb Res; 1994 Aug; 75(3):259-68. PubMed ID: 7992237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hageman factor activation by polysaccharides: effect of molecular weight.
    Silverberg M
    Adv Exp Med Biol; 1989; 247A():453-60. PubMed ID: 2481389
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of chemical modification of basic amino acid residues on the activation and amidolytic activity of Hageman factor (factor XII).
    Ryder J; Everson B; Jentoft J; Ratnoff OD
    J Lab Clin Med; 1993 Dec; 122(6):697-702. PubMed ID: 8245689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface-independent acceleration of factor XII activation by zinc ions. II. Direct binding and fluorescence studies.
    Bernardo MM; Day DE; Halvorson HR; Olson ST; Shore JD
    J Biol Chem; 1993 Jun; 268(17):12477-83. PubMed ID: 8509387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XI activation in a revised model of blood coagulation.
    Gailani D; Broze GJ
    Science; 1991 Aug; 253(5022):909-12. PubMed ID: 1652157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the contact system of coagulation by a monoclonal antibody directed against a neodeterminant in the heavy chain region of human coagulation factor XII (Hageman factor).
    Nuijens JH; Huijbregts CC; Eerenberg-Belmer AJ; Meijers JC; Bouma BN; Hack CE
    J Biol Chem; 1989 Aug; 264(22):12941-9. PubMed ID: 2473984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc ions promote the binding of factor XII/factor XIIA to acidic phospholipids but have no effect on the binding of high-Mr kininogen.
    Schousboe I; Halkier T
    Eur J Biochem; 1991 Apr; 197(2):309-14. PubMed ID: 2026153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics and mechanisms of surface-dependent coagulation factor XII activation.
    Terentyeva VA; Sveshnikova AN; Panteleev MA
    J Theor Biol; 2015 Oct; 382():235-43. PubMed ID: 26187095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface-dependent activation of human factor XII (Hageman factor) by kallikrein and its light chain.
    Rosing J; Tans G; Griffin JH
    Eur J Biochem; 1985 Sep; 151(3):531-8. PubMed ID: 3875484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.